Related Experiment Videos
Cellular pharmacology of quinone bioreductive alkylating agents
S Rockwell1, A C Sartorelli, M Tomasz
1Yale University School of Medicine, Department of Therapeutic Radiology, New Haven, CT 06510-8040.
Abstract:
The cellular pharmacology of the mitomycin bioreductive alkylating agents is complex. This reflects in part the chemical characteristics of these quinones, which have multiple sites of reactivity and the capacity to produce a large number of different lesions of biological importance. Moreover, at least six different enzymes are capable of activating these compounds; the nature of the active species and the resultant biological lesions can vary with the activating enzyme. The relative activities of these reductases vary in different cell lines and can be modulated by pH and oxygenation. The effects of a quinone bioreductive alkylating agent therefore depend upon both the cell line and the microenvironment. DNA damage appears to be critical to the cytotoxic effects of these compounds. Both monoadducts and bis-adducts (forming interstrand and intrastrand cross-links) have been identified in DNA from drug-treated cells. The pattern of adduct formation varies with the compound and the environment. Alkaline elution studies suggest a correlation between DNA cross-linking and cytotoxicity, both in air and in hypoxia. The rate of production of oxygen radicals and the importance of radical reactions in producing cytotoxic damage vary for different quinones and for different environments. While the potency of the bioreductive quinones varies with their redox potential, the direction and magnitude of the oxic/hypoxic differential cannot yet be predicted from the structures.
Insights
Bioreductive alkylating agents, like mitomycin, exhibit complex cellular pharmacology due to their chemical properties and enzyme activation. DNA damage, including cross-links, is critical for their cytotoxic effects, influenced by cell type and microenvironment.
Area of Science:
- Cellular pharmacology
- Medicinal chemistry
- Molecular biology
Background:
- Bioreductive alkylating agents, such as mitomycin, are complex quinones with multiple reactive sites.
- These agents can generate various DNA lesions, crucial for their biological activity.
- At least six different enzymes activate these compounds, influencing the active species and resulting DNA damage.
Purpose of the Study:
- To elucidate the complex cellular pharmacology of bioreductive alkylating agents.
- To understand the role of enzyme activation, chemical characteristics, and microenvironmental factors in drug effects.
- To investigate the relationship between DNA damage and cytotoxicity.
Main Methods:
- Analysis of quinone chemical characteristics and reactivity.
- Enzymatic activation studies using various reductases.
- Cell line studies examining effects of pH and oxygenation.
- DNA damage assessment using techniques like alkaline elution.
- Cytotoxicity assays under different environmental conditions.
Main Results:
- The cellular pharmacology is complex, influenced by quinone chemistry and multiple activating enzymes.
- DNA damage, including monoadducts and cross-links (interstrand and intrastrand), is critical for cytotoxicity.
- The pattern of DNA adducts and cytotoxicity varies with the specific agent, cell line, and microenvironment (pH, oxygenation).
- A correlation between DNA cross-linking and cytotoxicity was observed under both aerobic and hypoxic conditions.
- Oxygen radical production contributes to cytotoxicity, varying by quinone and environment.
Conclusions:
- The efficacy and mechanism of bioreductive alkylating agents are highly dependent on cellular and microenvironmental factors.
- DNA cross-linking is a key mechanism of cytotoxicity for these agents.
- Predicting the precise effects of these drugs based solely on structure and redox potential remains challenging.